ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 472,09
0,86%
Dow Jones
42 297,12
0,86%
DAX
20 248,51
0,55%
Brent Oil
80,325
0,06%
Bitcoin
96 802,89
2,43%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Femasys Inc (FEMY) Cours

Femasys Inc

Femasys Inc (FEMY)

NASDAQ
1,05
-0,03
(-2,78%)
Fermé 14 Janvier 10:00PM
Retardé de 15 minutes
1,05
0,00
( 0,00% )
Avant marché: 10:00AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,05
Prix Achat
0,98
Prix Vente
1,17
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,734 Plage de 52 semaines 2,40
Cap du marché
24,043M
Clôture Veille
1,05
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
186 900
Actions en circulation
22 898 468
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,69
Bénéfice par action (BPA)
-0,62
Chiffre d'affairess
1,07M
Bénéfice net
-14,25M

À propos de Femasys Inc

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in... Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.femasys.com
Siège social
Dover, Delaware, USA
Fondé
-
Femasys Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker FEMY. Le dernier cours de clôture d'Femasys était de US$1,05. Au cours de la dernière année, les actions de Femasys ont été négociées dans une fourchette de prix de US$ 0,734 à US$ 2,40.

Femasys compte actuellement 22 898 468 actions en circulation. La capitalisation boursière d'Femasys est de US$24,04 million. Femasys a un ratio cours/bénéfice (ratio PE) de -1.69.

FEMY Dernières nouvelles

Plus de nouvelles

Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

ATLANTA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

03 Décembre 2024
GlobeNewswire Inc.

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

26 Novembre 2024
GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]

12 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

12 Novembre 2024
GlobeNewswire Inc.

Femasys to Exhibit at the Annual AAGL 2024 Global Conference

ATLANTA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

07 Novembre 2024
GlobeNewswire Inc.

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

ATLANTA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

01 Novembre 2024
GlobeNewswire Inc.

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

30 Octobre 2024
GlobeNewswire Inc.

Form 8-K - Current report

29 Octobre 2024
Edgar (US Regulatory)

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

10 Octobre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.06-5.405405405411.111.151.04811851.08094787CS
4-0.09-7.894736842111.141.191.04997501.10448574CS
12-0.22-17.32283464571.271.40.861869001.14499367CS
26-0.08-7.07964601771.131.40.861595661.12440126CS
520.120312.93965795420.92972.40.7343098621.40396997CS
156-2.24-68.0851063833.294.750.247913516001.81039397CS
260-12.03-91.972477064213.0813.750.247911552371.90594781CS

FEMY - Frequently Asked Questions (FAQ)

What is the current Femasys share price?
The current share price of Femasys is US$ 1,05
How many Femasys shares are in issue?
Femasys has 22 898 468 shares in issue
What is the market cap of Femasys?
The market capitalisation of Femasys is USD 24,04M
What is the 1 year trading range for Femasys share price?
Femasys has traded in the range of US$ 0,734 to US$ 2,40 during the past year
What is the PE ratio of Femasys?
The price to earnings ratio of Femasys is -1,69
What is the cash to sales ratio of Femasys?
The cash to sales ratio of Femasys is 22,44
What is the reporting currency for Femasys?
Femasys reports financial results in USD
What is the latest annual turnover for Femasys?
The latest annual turnover of Femasys is USD 1,07M
What is the latest annual profit for Femasys?
The latest annual profit of Femasys is USD -14,25M
What is the registered address of Femasys?
The registered address for Femasys is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Femasys website address?
The website address for Femasys is www.femasys.com
Which industry sector does Femasys operate in?
Femasys operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STAFStaffing 360 Solutions Inc
US$ 4,68
(105,71%)
3,53M
PIIIP3 Partners Inc
US$ 0,3588
(66,96%)
11,95M
LGCBLinkage Global Inc
US$ 0,50
(28,87%)
1
GXAIGaxos ai Inc
US$ 2,15
(28,74%)
1,02M
SNESSenesTech Inc
US$ 3,79
(27,61%)
6
PHIOPhio Pharmaceuticals Corporation
US$ 5,07
(-23,18%)
227,9k
CTRNCiti Trends Inc
US$ 20,51
(-21,99%)
1
RIMEAlgorhythm Holdings Inc
US$ 0,079
(-21,39%)
2,37M
SASRSandy Spring Bancorp Inc
US$ 25,11
(-20,71%)
1
SVMHSRIVARU Holding Ltd
US$ 0,0279
(-20,51%)
3,36M
PIIIP3 Partners Inc
US$ 0,3588
(66,96%)
11,95M
LAESSEALSQ Corporation
US$ 3,95
(17,91%)
5,38M
GCTKGlucoTrack Inc
US$ 0,1324
(-11,56%)
4,31M
STAFStaffing 360 Solutions Inc
US$ 4,68
(105,71%)
3,53M
SVMHSRIVARU Holding Ltd
US$ 0,0279
(-20,51%)
3,36M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
FEMY
Femasys
LSE
0K19
Microchip Technology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés